
Prime Medicine, Inc.
PRMEHealthcare|Biotechnology|US
$4.65
+0.20 (+4.49%)
Tangible Book / Share
$0.22
Cash / Share
$0.54
Next Earnings Report
Mar 10, 2027
EPS est. -$0.23 · Revenue est. $6.6M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (2)
Dec 2027
Est. completion
Wilson Disease
Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial
NCT07226622n=30
Nov 2028
Est. completion
P1P2Wilson Disease
A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)
NCT07748403n=42
Recent Press Releases
Prime Drink Group Announces Subscription Receipt Financing and Closing of Second Tranche of Private Placement of Units
Oct 15, 2026 · Business Wire
Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease
Oct 5, 2026 · GlobeNewsWire
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency
Sep 24, 2026 · GlobeNewsWire
Prime Drink Group Provides Bi-Weekly MCTO Status Report
Sep 10, 2026 · GlobeNewsWire
Prime Medicine to Participate in Upcoming Investor Conferences
Sep 3, 2026 · GlobeNewsWire
SEC Filings (56)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Aug 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Jul 8, 2026 | 8-K | Material event | DocumentIndex |
| Jun 8, 2026 | 8-K | Material event | DocumentIndex |
| May 7, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| Apr 23, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 23, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 23, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 16, 2026 | 8-K | Material event | DocumentIndex |
| Mar 4, 2026 | EFFECT | DocumentIndex | |
| Mar 3, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 3, 2026 | POS AM | DocumentIndex | |
| Mar 3, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 3, 2026 | POSASR | DocumentIndex | |
| Mar 3, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 12, 2026 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 12, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 7, 2025 | S-3ASR | Shelf registration | DocumentIndex |
| Nov 7, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 7, 2025 | 8-K | Material event | DocumentIndex |
| Nov 5, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Sep 8, 2025 | 8-K | Material event | DocumentIndex |
| Aug 11, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 7, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 7, 2025 | 8-K | Material event | DocumentIndex |
| Aug 5, 2025 | 8-K | Material event | DocumentIndex |
| Jul 31, 2025 | 8-K | Material event | DocumentIndex |
| Jul 31, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Jul 30, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Jul 30, 2025 | 8-K | Material event | DocumentIndex |
| Jul 15, 2025 | 8-K | Material event | DocumentIndex |
| Jul 14, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jul 2, 2025 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 5, 2025 | 8-K | Material event | DocumentIndex |
| May 19, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| May 19, 2025 | 8-K | Material event | DocumentIndex |
| May 8, 2025 | 10-Q | Quarterly report | DocumentIndex |